Drugs

Explore key questions to ask before obtaining GLP-1 weight-loss drugs online and learn about the trade-offs of this booming telehealth market.

The FDA is considering tighter limits on compounded semaglutide and tirzepatide, raising questions about safety, access, cost, and the future of copycat GLP-1 weight loss and diabetes medications.

New research suggests even light or moderate alcohol use may affect brain structure over time, raising concerns about memory, cognitive aging, and long-term brain health.

GLP-1 receptor agonists are popular for type 2 diabetes and obesity management, but their effectiveness varies due to genetics, lifestyle, and insulin resistance. Personalized care and alternative treatments can help those who find these medications less effective.

Lithium is a key treatment for bipolar disorder but raises concerns about cognitive side effects like memory loss. While some studies suggest mild cognitive impacts, definitive links to significant memory loss are limited, and it may even offer neuroprotective benefits.

Recent research indicates that daily aspirin may not significantly reduce colorectal cancer risk as once believed, challenging previous assumptions about its preventive benefits. Personalized medical advice is crucial, highlighting the importance of lifestyle changes and regular screenings for cancer prevention.

Weight loss medications offer benefits like reduced appetite but pose risks, including potential pancreatitis. Understanding these risks and consulting healthcare providers is essential for informed use, alongside lifestyle changes to enhance effectiveness and minimize side effects.

Pancreatic cancer is highly aggressive with poor prognosis. Recent research shows promise with a three-drug combination that could improve treatment outcomes, offering hope for patients with advanced stages of the disease.

Recent research on rheumatoid arthritis suggests pre-treatment strategies could delay its onset, providing those at high risk more time to manage symptoms and improve quality of life. This proactive approach targets early intervention before symptoms appear.

The connection between smoking, vaping, and nicotine pouches with type 2 diabetes risk is a public health concern. Nicotine, regardless of delivery method, may increase diabetes risk by causing insulin resistance, highlighting the need for awareness and preventive strategies.

Recent studies reveal that LSD, a powerful psychedelic, may alleviate anxiety symptoms, offering an alternative for those not finding relief through traditional methods. The drug's interaction with serotonin receptors could play a crucial role in reducing anxiety.

GLP-1 receptor agonists like Ozempic are popular for weight management, originally developed for diabetes. Concerns about muscle loss exist, but recent findings suggest it's less significant, highlighting the importance of combining medication with lifestyle changes for effective weight management.